Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (NYSE:HIMS), filed a Form 4 on November 18, 2026, disclosing the sale of Class A Common Stock on November 17, 2026.

Key Highlights

  • Reporting person: Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc.
  • Shares sold: 3,458 shares of Class A Common Stock disposed of on November 17, 2026
  • Sale price: $18.53 per share
  • Remaining holdings: 311,190 shares of Class A Common Stock beneficially owned directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026
  • Filing signed by: Kimberly Mather, Attorney-in-Fact for Soleil Boughton, on November 18, 2026

Boughton Sale Details and 10b5-1 Plan Background

According to the Form 4 filed with the SEC on November 18, 2026, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., disposed of 3,458 shares of Class A Common Stock on November 17, 2026, at a price of $18.53 per share. The transaction was coded "S," indicating a sale, and the shares were directly owned by the reporting person.

The filing notes that "the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person." Following the reported transaction, Boughton directly holds 311,190 shares of Class A Common Stock, according to the filing. No derivative securities transactions were reported in Table II of the form.

The form was filed on behalf of the reporting person by Kimberly Mather, identified as Attorney-in-Fact for Soleil Boughton, and bears a signature date of November 18, 2026. The filing also indicates that the transaction was made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c).

What Was Disclosed

The Form 4 disclosed the sale of 3,458 shares of Hims & Hers Health Class A Common Stock by Chief Legal Officer Soleil Boughton at $18.53 per share on November 17, 2026, executed under a Rule 10b5-1 trading plan adopted May 21, 2026, leaving 311,190 shares directly held.